APA (7th ed.) Citation

N, C., E, V., R, L., KP, Y., AM, D., BA, N., . . . AJ, S. (2024). PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease. Hepatology (Baltimore, Md.), 80(5), 1212. https://doi.org/10.1097/HEP.0000000000000896

Chicago Style (17th ed.) Citation

N, Chalasani, et al. "PNPLA3 Rs738409, Age, Diabetes, Sex, and Advanced Fibrosis Jointly Contribute to the Risk of Major Adverse Liver Outcomes in Metabolic Dysfunction-associated Steatotic Liver Disease." Hepatology (Baltimore, Md.) 80, no. 5 (2024): 1212. https://doi.org/10.1097/HEP.0000000000000896.

MLA (9th ed.) Citation

N, Chalasani, et al. "PNPLA3 Rs738409, Age, Diabetes, Sex, and Advanced Fibrosis Jointly Contribute to the Risk of Major Adverse Liver Outcomes in Metabolic Dysfunction-associated Steatotic Liver Disease." Hepatology (Baltimore, Md.), vol. 80, no. 5, 2024, p. 1212, https://doi.org/10.1097/HEP.0000000000000896.